Related Experiment Videos
Synthesis and binding affinity of bidentate phenothiazines with two different photoactive groups
M Golinski1, P J DeLaLuz, T J Delcamp
1Department of Chemistry, University of Kentucky, Lexington 40506, USA.
Bioconjugate Chemistry
|September 1, 1995
Summary
Researchers developed novel photoaffinity reagents to map calmodulin (CaM) interactions. Modified phenothiazines successfully inhibited calmodulin-mediated phosphodiesterase activation, showing promise for drug development.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Molecular Biology
Background:
- Calmodulin (CaM) is a crucial calcium-binding protein regulating numerous enzymes.
- Understanding CaM-enzyme interactions is vital for drug discovery.
- Phenothiazines are known to interact with CaM, but targeted reagents are needed.
Purpose of the Study:
- To synthesize and evaluate bidentate photoaffinity reagents for mapping CaM-enzyme interaction domains.
- To develop novel phenothiazine derivatives with dual photoactive groups for cross-linking studies.
Main Methods:
- Synthesis of various phenothiazine derivatives incorporating 3-azidophenothiazine and benzophenone photoactive groups.
- Evaluation of binding affinity and inhibitory activity against calmodulin-mediated phosphodiesterase.
- Modification of phenothiazine structures with quaternary ammonium salts, amino acids, or carbohydrates to improve properties.
Main Results:
- Successfully synthesized phenothiazines with dual photoactive groups (3-azidophenothiazine and benzophenone).
- Identified structural modifications (quaternary ammonium salt) that enhanced solubility and inhibitory activity.
- Phenothiazines with quaternary N-methylammonium iodide moiety inhibited calmodulin-mediated phosphodiesterase activation comparably to chlorpromazine.
Conclusions:
- Novel bidentate photoaffinity reagents based on phenothiazines were successfully developed.
- Structural modifications are key to overcoming challenges in solubility and activity for CaM-targeting reagents.
- These reagents show potential for elucidating CaM-enzyme binding sites and guiding the development of new therapeutics.